Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and health care issues, announced today the availability of Developmental Drug Review, a series of competitive analysis reports that profiles and comparatively ranks compounds being developed for central nervous system (CNS) diseases and metabolic disorders. The reports examine key compounds by drug class and provide assessments of their clinical potential, rationales behind the assessments, current developmental status and the status of any licensing agreements.
Titan Pharmaceuticals, a biopharmaceutical company located in South San Francisco, California, recently reviewed Developmental Drug Review's Parkinson's Disease Drugs.
"The Developmental Drug Review for Parkinson's disease provided us with a consolidated review of publicly available and proprietary data sources in one easy-to-understand book," said Lynne Jacobson, senior director of corporate development at Titan. "The insight that Decision Resources provides in this Parkinson's disease drugs report contributed to our understanding of the product development opportunities in Parkinson's disease."
Drug classes covered in the Developmental Drug Review series include: * CNS Disorders Alzheimer's disease & Dementia drugs Antiepileptic drugs Migraine drugs Multiple sclerosis drugs Neuroprotectants Pain drugs Parkinson's disease Psychiatric Antidepressants Antipyschotic drugs Anxiolytics * Metabolic Disorders Osteoporosis Bone-forming drugs Bone resorption inhibitors (HRT) Bone resorption inhibitors (non-HRT) Obesity Obesity (central) Obesity (peripheral) Type I & II Diabetes Cell therapies Insulin (rapid/short acting) Insulin (intermediate/long acting) Insulin sensitizers Insulin secretagogues Immunomodulators Metabolic modulators About Decision Resources
Decision Resources, Inc., is a world leader in research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets. The company provides strategic information services and assesses international pharmaceutical and health care industry trends. Visit Decision Resources at www.decisionresources.com.
All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.
For more information, contact: Elizabeth Marshall Decision Resources, Inc. 781-296-2563 email@example.com
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20000303/DECISION
AP Archive: http://photoarchive.ap.org/
PRN Photo Desk, 888-776-6555 or 212-782-2840
SOURCE: Decision Resources, Inc.
CONTACT: Elizabeth Marshall of Decision Resources, Inc., +1-781-296-2563,
Web site: http://www.dresources.com/